D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMTK
3051
DELISTED
DermTech, Inc. Common Stock
DMTK
| $912K | ﹤0.01% |
+17,961
| New | +$939K |
|
3052
Exponent
EXPO
$3.04B
| $909K | ﹤0.01% |
9,327
+6,219
| +200% | +$583K |
|
3053
LeMaitre Vascular
LMAT
$2.26B
| $909K | ﹤0.01% |
18,631
+5,555
| +42% | +$260K |
|
3054
Amalgamated Financial
AMAL
$1.46B
| $905K | ﹤0.01% |
54,526
-943
| -2% | -$15.3K |
|
|
BLUE
3055
PUT
DELISTED
bluebird bio
BLUE
| $905K | ﹤0.01% |
2,316
-3,837
| -62% | -$1.89M |
|
3056
PUT
AutoNation
AN
$7.1B
| $904K | ﹤0.01% |
+9,700
| New | +$778K |
|
3057
Madrigal Pharmaceuticals
MDGL
$12.7B
| $903K | ﹤0.01% |
7,718
+3,901
| +102% | +$455K |
|
|
CNR
3058
Core Natural Resources Inc
CNR
$4.16B
| $903K | ﹤0.01% |
92,883
-264,837
| -74% | -$2.59M |
|
|
TAST
3059
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $903K | ﹤0.01% |
+150,924
| New | +$984K |
|
|
SGMO
3060
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $899K | ﹤0.01% |
71,708
-375,298
| -84% | -$5.06M |
|
|
SYKE
3061
DELISTED
SYKES Enterprises Inc
SYKE
| $898K | ﹤0.01% |
20,376
-2,956
| -13% | -$125K |
|
3062
Smith & Wesson
SWBI
$666M
| $897K | ﹤0.01% |
51,379
-37,677
| -42% | -$685K |
|
|
LOMA
3063
Loma Negra
LOMA
$1.36B
| $892K | ﹤0.01% |
140,890
+32,995
| +31% | +$188K |
|
3064
PUT
Shutterstock
SSTK
$216M
| $890K | ﹤0.01% |
+10,000
| New | +$800K |
|
3065
CALL
Stellantis
STLA
$16.5B
| $890K | ﹤0.01% |
50,000
-367,600
| -88% | -$6.18M |
|
3066
Watts Water Technologies
WTS
$11.5B
| $889K | ﹤0.01% |
7,485
+2,769
| +59% | +$338K |
|
3067
CALL
Suncor Energy
SU
$75.6B
| $886K | ﹤0.01% |
42,400
-44,600
| -51% | -$874K |
|
3068
PPG Industries
PPG
$26.4B
| $885K | ﹤0.01% |
5,891
+3,839
| +187% | +$550K |
|
3069
CALL
D.R. Horton
DHI
$41.3B
| $882K | ﹤0.01% |
9,900
-38,100
| -79% | -$2.98M |
|
3070
Banco Macro
BMA
$5.89B
| $881K | ﹤0.01% |
66,006
-151,165
| -70% | -$2.14M |
|
3071
Noodles & Co
NDLS
$84M
| $881K | ﹤0.01% |
10,637
+3,994
| +60% | +$310K |
|
3072
Koppers
KOP
$954M
| $879K | ﹤0.01% |
25,274
-48,098
| -66% | -$1.69M |
|
3073
Infosys
INFY
$47.4B
| $877K | ﹤0.01% |
+46,852
| New | +$848K |
|
|
AXON
3074
Axon Enterprise
AXON
$42.4B
| $875K | ﹤0.01% |
6,142
-84,691
| -93% | -$13.2M |
|
3075
PUT
HSBC
HSBC
$357B
| $874K | ﹤0.01% |
30,000
-185,000
| -86% | -$5.29M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.